Back

Role of Vericiguat on clinical, echocardiographic and comprehensive geriatric assessment parameters in elderly patients with worsening Heart Failure

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Updates in advanced and acute heart failure Multidisciplinary Interventions HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Giuseppe Armentaro

University Hospital Renato Dulbecco, Catanzaro (Italy)

4 More presentations in this session

Presentation thumbnail
Intravenous nitroglycerin improves decongestion in a propensity matched acute heart failure cohort.
Doctor M. Hoen (Heerlen, NL)
Abstract Slides Video
Presentation thumbnail
Acute heart failure patients with iron deficiency: does etiology really matter?
Doctor J. Ferraro (Penafiel, PT)
Abstract Slides Video
Presentation thumbnail
PRACTICE-HF : an implementation study of an updated acute heart failure protocol.
Mr L. Peeters (Heerlen, NL)
Abstract Slides Video
Presentation thumbnail
Hospital admissions and long-term outcomes in advanced heart failure patients with persistent congestion treated with sustained low-efficiency dialysis
Doctor T. Furlan (Trbovlje, SI)
Abstract Slides Video

Access the full session

Session thumbnail
Updates in advanced and acute heart failure

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Clinical profile of heart failure patients starting vericiguat in clinical practice
thumbnail
Congress Presentation
Vericiguat in heart failure patients: analyzing safety, tolerability, and quality of life via meta-analysis of randomized controlled trials
thumbnail
Congress Presentation
The impact of a cardio-geriatric integrated care on mortality and readmissions in older patients with Heart Failure. Results of a quasi-experimental study.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources